Date published: 2025-9-14

1-800-457-3801

SCBT Portrait Logo
Seach Input

FAM54B Inhibitors

FAM54B inhibitors comprise a diverse array of compounds that reduce the activity of FAM54B by altering specific cellular pathways. For instance, Taxol hampers cell division by stabilizing microtubules, which could lead to a reduction in FAM54B activity by curtailing the cellular proliferation necessary for its function. Staurosporine, a broad-spectrum kinase inhibitor, predominantly targets PKC, potentially decreasing FAM54B activity if it is influenced by PKC-mediated signaling. Rapamycin, by binding to mTORC1, inhibits a central pathway regulating cell growth, which may result in diminished FAM54B activity if FAM54B is implicated in mTORC1-linked processes. Sorafenib's inhibition of various tyrosine kinases and the Raf family could similarly result in the attenuation of FAM54B activity by influencing signaling pathways that regulate FAM54B-related cellular functions.

The activity of FAM54B is further influenced by chemicals that affect gene expression and protein stability. Trichostatin A, by inhibiting histone deacetylases, alters gene expression profiles, which could lead to a decreased FAM54B activity through modifications in the expression of genes interacting with or regulating FAM54B. Bortezomib, by inhibiting the proteasome, could stabilize proteins involved in cell cycle regulation, potentially affecting FAM54B if it is associated with such regulatory mechanisms. Autophagy inhibitors like Chloroquine, along with PI3K pathway inhibitors LY 294002 and Wortmannin, may also contribute to the reduced activity of FAM54B by altering autophagy processes and PI3K/Akt signaling, where FAM54B may be implicated. Additionally, U0126, through its selective inhibition of MEK1/2, indirectly affects the MAPK/ERK pathway, which could lead to a decrease in FAM54B activity if it is associated with MAPK/ERK signaling. Collectively, these FAM54B inhibitors, through targeted effects on distinct cellular pathways, contribute to the downregulation of FAM54B activity without directly modifying its expression or function.

SEE ALSO...

Items 11 to 12 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$63.00
$241.00
136
(2)

U0126 is a selective inhibitor of MEK1/2, which indirectly affects the MAPK/ERK signaling pathway. By inhibiting this pathway, it could lead to a decrease in FAM54B activity if FAM54B is associated with MAPK/ERK signaling.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

Wortmannin is another potent PI3K inhibitor, which diminishes the PI3K/Akt signaling pathway. By inhibiting PI3K, it could indirectly lead to a reduction in FAM54B activity, similarly to LY294002, if FAM54B is associated with this signaling pathway.